Product image of Montelucaste Accord (Montelukast Sodium) supplied by GNH India

Montelucaste Accord

Active Ingredient:
Montelukast Sodium
Origin:
EU

Montelucaste Accord (Montelukast Sodium)

Montelukast, the active ingredient in Montelucaste Accord, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma, allergic rhinitis and exercise‑induced bronchoconstriction in patients requiring anti‑asthmatic therapy.

GNH India supplies Montelucaste Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montelucaste Accord is a leukotriene receptor antagonist indicated for several respiratory conditions:

  • Asthma: improves control of chronic airway inflammation and reduces frequency of wheezing episodes.
  • Allergic rhinitis: alleviates nasal congestion, sneezing and itching caused by seasonal allergens.
  • Exercise‑induced bronchoconstriction: prevents narrowing of airways triggered by physical activity.

How It Works

  • Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes from binding and triggering bronchoconstriction, mucus secretion, and inflammatory cell recruitment. By inhibiting this pathway, the drug reduces airway edema and hyper‑responsiveness, contributing to improved respiratory function in asthma and related allergic conditions.

Side Effects

Montelucaste Accord may be associated with a range of adverse reactions.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Upper respiratory tract infection: symptoms of cough or sore throat.
  • Abdominal pain: occasional discomfort or cramping.
  • Dyspepsia: indigestion or heartburn.
  • Cough: non‑productive cough episodes.
  • Fatigue: feeling unusually tired.

Serious or Rare Side Effects

  • Mood changes: depression, anxiety, or suicidal thoughts.
  • Allergic reactions: rash, urticaria, or angioedema.
  • Hepatotoxicity: elevated liver enzymes or hepatitis.
  • Stevens‑Johnson syndrome: severe skin blistering.
  • Anaphylaxis: rapid onset of breathing difficulty and hypotension.

Precautions & Warnings

Before prescribing Montelucaste Accord, consider the following safety measures:

  • Pregnancy: consult a healthcare professional; safety data are limited.
  • Breastfeeding: assess risk versus benefit; drug may pass into milk.
  • Hepatic impairment: use with caution; monitor liver function.
  • Neuropsychiatric events: observe for mood changes or suicidal ideation.
  • Drug interactions: review concomitant medications for potential CYP450 effects.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Avoid Interactions

Montelucaste Accord can interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

  • Phenobarbital: may reduce montelukast plasma concentrations.
  • Rifampin: induces metabolism, potentially lowering efficacy.

Moderate Interactions (Monitor Closely)

  • Antidepressants (e.g., fluoxetine): possible additive neuropsychiatric effects.
  • Antihistamines: may increase sedation.
  • Warfarin: monitor INR as occasional alterations reported.
  • St. John's wort: may decrease drug exposure.
  • Erythromycin: potential increase in montelukast levels.

Frequently Asked Questions

Montelucaste Accord contains montelukast, which is prescribed for the management of asthma, allergic rhinitis and exercise‑induced bronchoconstriction. It helps control airway inflammation, reduces nasal allergy symptoms, and prevents airway narrowing during physical activity.

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This inhibition prevents leukotrienes from causing bronchoconstriction, mucus production, and inflammation, thereby improving breathing and reducing allergic symptoms.

The appropriate dose of Montelucaste Accord is determined by a qualified prescriber based on the patient’s age, condition severity, and clinical response. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for montelukast in pregnancy are limited, so the drug should only be used if the potential benefit justifies the potential risk. Montelukast does pass into breast milk; therefore, a healthcare professional should evaluate the risk‑benefit ratio for nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting bronchodilators. It is particularly useful for patients with aspirin‑sensitive asthma or those who prefer a once‑daily tablet, though it may be used in combination with other controller therapies.

Montelucaste Accord should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Montelucaste Accord is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or split unless specifically instructed by a healthcare provider.

Serious adverse events, although rare, include neuropsychiatric reactions such as depression, anxiety, suicidal thoughts, as well as severe allergic responses like Stevens‑Johnson syndrome and anaphylaxis. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelucaste Accord is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. Patients with a history of severe neuropsychiatric disorders should use the medication only under close medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT